文献速递心境障碍

健康志愿者中麦角酸二乙酰胺微剂量急性主观与行为效应

Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.
PubMed 文献 · Biol Psychiatry · 2019-06-03

本研究在双盲条件下,对20名健康年轻成人单次给予0、6.5、13、26 μg 麦角酸二乙酰胺(LSD),评估主观情绪、情绪加工与认知任务及生理指标。结果显示LSD产生剂量相关的主观效应,最高剂量增加活力评分并轻微降低正性情绪图片的正性评级,其他情绪、认知和生理指标未受影响。结论提示13 μg可能为安全重复给药的阈值剂量。

要点

  • LSD微剂量在6.5–26 μg范围内产生剂量相关的主观效应。
  • 26 μg可增加活力评分并轻微降低正性情绪图片的正性评级。
  • 其他情绪、认知及生理指标未受显著影响,13 μg或可作为重复给药阈值。

核心结论

  • 单次LSD微剂量在健康志愿者中产生有序的剂量相关主观效应。
  • 13 μg的LSD可能是安全进行重复给药研究的阈值剂量。
  • 该药是否改善抑郁症状个体的情绪或认知尚待确定。

研究设计与样本

  • 双盲、安慰剂对照、随机顺序的实验室研究。
  • 健康年轻成人共20人,参加4次实验室会话,间隔1周,分别接受0、6.5、13、26 μg LSD。
  • 在预期药物峰值效应期间完成情绪问卷、情绪加工与认知行为任务,并评估心血管指标和体温。

主要发现

  • LSD在6.5、13、26 μg三个剂量上产生剂量相关的主观效应。
  • 最高剂量(26 μg)增加活力评分,并轻微降低正性情绪内容图片的正性评级。
  • 其他情绪测量、认知及生理指标未受影响。

临床怎么用

  • 提示13 μg LSD可能作为未来重复给药研究的阈值剂量。
  • 临床应用中需注意26 μg单次给药可轻微改变正性情绪加工和活力评分。
  • 目前证据仅来自健康志愿者单次给药,不能推断对抑郁症状个体的疗效。

局限性

  • 样本量小(N=20),仅纳入健康年轻成人。
  • 仅评估单次给药急性效应,未测试重复给药。
  • 未纳入抑郁症状个体,结论不能外推至临床人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Numerous anecdotal reports suggest that repeated use of very low doses of lysergic acid diethylamide (LSD), known as microdosing, improves mood and cognitive function. These effects are consistent both with the known actions of LSD on serotonin receptors and with limited evidence that higher doses of LSD (100-200 μg) positively bias emotion processing. Yet, the effects of such subthreshold doses of LSD have not been tested in a controlled laboratory setting. As a first step, we examined the effects of single very low doses of LSD (0-26 μg) on mood and behavior in healthy volunteers under double-blind conditions. METHODS: Healthy young adults (N = 20) attended 4 laboratory sessions during which they received 0 (placebo), 6.5, 13, or 26 μg of LSD in randomized order at 1-week intervals. During expected peak drug effect, they completed mood questionnaires and behavioral tasks assessing emotion processing and cognition. Cardiovascular measures and body temperature were also assessed. RESULTS: LSD produced dose-related subjective effects across the 3 doses (6.5, 13, and 26 μg). At the highest dose, the drug also increased ratings of vigor and slightly decreased positivity ratings of images with positive emotional content. Other mood measures, cognition, and physiological measures were unaffected. CONCLUSIONS: Single microdoses of LSD produced orderly dose-related subjective effects in healthy volunteers. These findings indicate that a threshold dose of 13 μg of LSD might be used safely in an investigation of repeated administrations. It remains to be determined whether the drug improves mood or cognition in individuals with symptoms of depression.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bershad AK, Schepers ST, Bremmer MP, et al. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers. Biol Psychiatry. 2019. PMID: 31331617. doi:10.1016/j.biopsych.2019.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。